ACCOUNTS - Final Accounts

JULIA TERTERYAN THERAPY LIMITED - Company Information

Caseware UK (AP4) 2022.0.179 2022.0.179 2022-07-312022-07-312021-08-01falseprovision of occupational therapy services86truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 07510199 2021-08-01 2022-07-31 07510199 2020-08-01 2021-07-31 07510199 2022-07-31 07510199 2021-07-31 07510199 c:Director1 2021-08-01 2022-07-31 07510199 d:OfficeEquipment 2021-08-01 2022-07-31 07510199 d:ComputerEquipment 2021-08-01 2022-07-31 07510199 d:OtherPropertyPlantEquipment 2021-08-01 2022-07-31 07510199 d:OtherPropertyPlantEquipment 2022-07-31 07510199 d:OtherPropertyPlantEquipment 2021-07-31 07510199 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2021-08-01 2022-07-31 07510199 d:Goodwill 2022-07-31 07510199 d:Goodwill 2021-07-31 07510199 d:CurrentFinancialInstruments 2022-07-31 07510199 d:CurrentFinancialInstruments 2021-07-31 07510199 d:CurrentFinancialInstruments d:WithinOneYear 2022-07-31 07510199 d:CurrentFinancialInstruments d:WithinOneYear 2021-07-31 07510199 d:ShareCapital 2022-07-31 07510199 d:ShareCapital 2021-07-31 07510199 d:RetainedEarningsAccumulatedLosses 2022-07-31 07510199 d:RetainedEarningsAccumulatedLosses 2021-07-31 07510199 c:FRS102 2021-08-01 2022-07-31 07510199 c:AuditExempt-NoAccountantsReport 2021-08-01 2022-07-31 07510199 c:FullAccounts 2021-08-01 2022-07-31 07510199 c:PrivateLimitedCompanyLtd 2021-08-01 2022-07-31 iso4217:GBP xbrli:pure

Registered number: 07510199

JULIA TERTERYAN THERAPY LIMITED

UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JULY 2022

JULIA TERTERYAN THERAPY LIMITED

REGISTERED NUMBER: 07510199

BALANCE SHEET

AS AT 31 JULY 2022

		2022		2021
Note		£		£

Fixed assets
Tangible assets	5		2,138		2,816
			2,138		2,816
Current assets
Debtors: amounts falling due within one year	6	51,540		40,287
Cash at bank and in hand	7	37,557		56,469
		89,097		96,756
Creditors: amounts falling due within one year	8	(90,703)		(98,922)
Net current liabilities			(1,606)		(2,166)
Total assets less current liabilities			532		650
Provisions for liabilities
Deferred tax		(423)		(496)
			(423)		(496)
Net assets			109		154

Capital and reserves
Called up share capital	100	100
Profit and loss account	9	54
	109	154

Page 1

JULIA TERTERYAN THERAPY LIMITED

REGISTERED NUMBER: 07510199

BALANCE SHEET (CONTINUED)

AS AT 31 JULY 2022

The Director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

J Terteryan

Director

Date: 25 April 2023

The notes on pages 3 to 8 form part of these financial statements.

Page 2

JULIA TERTERYAN THERAPY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2022

1.	General information

Julia Terteryan Therapy Limited is a Company limited by shares and incorporated in England & Wales under the Companies Act 2006. The address of the registered office is given on the Compnay information page. The nature of the Company's operations and its principal activities are set out in the Directors’ report.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

2.2

Going concern

The COVID-19 (coronavirus) pandemic has had a significant effect on individuals, businesses and organisations worldwide, including Julia Terteryan Therapy Ltd. The outbreak came into widespread public knowledge in 2020. The Directors have taken all necessary measures to satisfy themselves that the Company will continue to be able to operate throughout the current conditions and beyond. Therefore, the Company is considered to be a going concern and no adjustments have been made to the figures in these financial statements.
The Directors have considered the effect on the value of the assets and liabilities of the Company since the balance sheet date, as well as actual and expected future income and expenditure, cash flow requirements and the Company’s ability to continue as a going concern. They have taken steps to protect the workforce and the business, including its cash flow, so as to be able to maintain liquidity given that the effects of the current crisis are likely to last for several months.

2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of revenue can be measured reliably;

∙it is probable that the Company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

JULIA TERTERYAN THERAPY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2022

2.Accounting policies (continued)

2.4

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Profit and loss account in the same period as the related expenditure.

2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

2.7

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

2.8

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

2.9

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 4

JULIA TERTERYAN THERAPY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2022

2.Accounting policies (continued)

2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

				Office equipment	-	20% Straightline
				Computer equipment	-	20% Straightline

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

2.11

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

2.12

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

2.13

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

2.14

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance sheet.

Page 5

JULIA TERTERYAN THERAPY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2022

2.Accounting policies (continued)

2.15

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

2.16

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Employees

The average monthly number of employees, including directors, during the year was 8 (2021 - 6).

4.	Intangible assets

		Goodwill
		£
	Cost
	At 1 August 2021	10,500
	At 31 July 2022	10,500
	Amortisation
	At 1 August 2021	10,500
	At 31 July 2022	10,500
	Net book value
	At 31 July 2022	-
	At 31 July 2021	-

Page 6

JULIA TERTERYAN THERAPY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2022

5.	Tangible fixed assets

		Plant and machinery etc
		£
	Cost or valuation
	At 1 August 2021	9,204
	Additions	1,148
	Disposals	(730)
	At 31 July 2022	9,622
	Depreciation
	At 1 August 2021	6,388
	Charge for the year on owned assets	1,826
	Disposals	(730)
	At 31 July 2022	7,484
	Net book value
	At 31 July 2022	2,138
	At 31 July 2021	2,816

Debtors

					2022	2021
					£	£


Trade debtors	13,846	11,434
Other debtors	37,334	25,958
Prepayments and accrued income	360	2,895
	51,540	40,287

Included within other debtors due within one year is a loan to a Director, amounting to £21,213 (2021 - £9,837). This is repayable on demand and no interest has been charged.

Page 7

JULIA TERTERYAN THERAPY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2022

7.	Cash and cash equivalents
		2022	2021
		£	£

Cash at bank and in hand	37,557	56,469
	37,557	56,469

8.	Creditors: Amounts falling due within one year
		2022	2021
		£	£

Bank loans	32,667	35,000
Trade creditors	-	70
Corporation tax	50,435	55,541
Other taxation and social security	452	1,462
Other creditors	448	2,240
Accruals and deferred income	6,701	4,609
	90,703	98,922

Page 8